Clinical Experience of the Surgical Treatment of Cardiac Tumor.
- Author:
Jung Hee BANG
1
;
Jong Soo WOO
;
Pill Jo CHOI
;
Gwang Jo CHO
;
Si Ho KIM
;
Kwon Jae PARK
Author Information
1. Department of Thoracic and Cardiovascular Surgery, Dong-A Medical Hospital, Korea. jswoo@dau.ac.kr
- Publication Type:Original Article
- Keywords:
Heart neoplasms;
Myxoma;
Sarcoma
- MeSH:
Aged;
Axis, Cervical Vertebra;
Biopsy;
Dyspnea;
Echocardiography;
Embolism;
Emergencies;
Female;
Follow-Up Studies;
Heart Atria;
Heart Failure;
Heart Neoplasms;
Heart Ventricles;
Humans;
Lipoma;
Male;
Medical Records;
Mitral Valve;
Myxoma;
Neoplasm Metastasis;
Outpatients;
Prognosis;
Quality of Life;
Recurrence;
Retrospective Studies;
Sarcoma
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
2010;43(4):375-380
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Primary cardiac tumors are extremely rare. The most common type are benign myxomas, and these are almost completely curable with early surgery. Malignant tumors, however, such as sarcomas, are difficult to remove surgically, and their prognosis is known to be poor. In this study, data on patients who had undergone surgical treatment of cardiac tumor in the authors' hospital were collected and analyzed. MATERIAL AND METHOD: The subjects included 28 patients who had undergone surgical treatment of cardiac tumor from August 1993 to December 2008. Their medical records were reviewed and retrospectively analyzed. RESULT: The patients were aged from 20 to 76 years (mean age: 54.2+/-15.6), and 11 were male (39%) and 17 female (61%). Fifteen of them (54%) underwent emergency surgery to improve heart failure symptoms. The most common preoperative symptom was dyspnea (15 cases, 54%). Preoperative echocardiography was performed on all the patients. The average size of the tumor as measured during the operation was 7.0+/-6.9 cm (the average length of the long axis was 2~40 cm), and the sites of tumor attachment were the interatrial septum (18 cases, 64%), the left atrium (9 cases, 32%), the mitral valve annulus (2 cases, 7%), and the left ventricle (2 cases, 7%). The operation was performed with an incision through both atria in all the patients, and a complete excision was made in 25 cases (89%). According to the biopsy results, there were 4 cases of sarcoma (14%), 1 case of lipoma (4%), and 23 cases of myxoma (82%). The three cases in which the tumors were not completely excised were sarcomas. No operative deaths occurred after the operations. Outpatient follow-up was possible for 24 cases (86%), with a mean follow-up period of 46.8+/-42.7 months. Late death occurred in 3 of the 24 patients; each of these patients had sarcomas. Of these patients, the first had undergone two repeat surgeries, the second had metastatic sites removed, and the last had only chemotherapy. The average recurrence time was 12.7+/-10.8 months, and the average metastasis time was 20.5+/-16.8 months. CONCLUSION: Most cardiac tumors are benign myxomas. In principle, they should be surgically treated because they can create risks such as embolism, and can be radically treated when surgically removed. In most cases, however, malignant sarcomas are already considerably advanced with severe infiltration into the neighboring tissues at the time of diagnosis. The surgical removal of malignant sarcomas is known to be difficult because of the advanced stage and degree of infiltration. We suggest that excision of the removable portion of the tumor sites to alleviate symptoms such as heart failure can improve quality of life.
